Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Mol Psychiatry ; 18(6): 729-37, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22584869

RESUMEN

Defining the drug-induced neuroadaptations specifically associated with the behavioral manifestation of addiction is a daunting task. To address this issue, we used a behavioral model that differentiates rats controlling their drug use (Non-Addict-like) from rats undergoing transition to addiction (Addict-like). Dysfunctions in prefrontal cortex (PFC) synaptic circuits are thought to be responsible for the loss of control over drug taking that characterizes addicted individuals. Here, we studied the synaptic alterations in prelimbic PFC (pPFC) circuits associated with transition to addiction. We discovered that some of the changes induced by cocaine self-administration (SA), such as the impairment of the endocannabinoid-mediated long-term synaptic depression (eCB-LTD) was similarly abolished in Non-Addict- and Addict-like rats and thus unrelated to transition to addiction. In contrast, metabotropic glutamate receptor 2/3-mediated LTD (mGluR2/3-LTD) was specifically suppressed in Addict-like rats, which also show a concomitant postsynaptic plasticity expressed as a change in the relative contribution of AMPAR and NMDAR to basal glutamate-mediated synaptic transmission. Addiction-associated synaptic alterations in the pPFC were not fully developed at early stages of cocaine SA, when addiction-like behaviors are still absent, suggesting that pathological behaviors appear once the pPFC is compromised. These data identify specific synaptic impairments in the pPFC associated with addiction and support the idea that alterations of synaptic plasticity are core markers of drug dependence.


Asunto(s)
Cocaína/efectos adversos , Inhibidores de Captación de Dopamina/efectos adversos , Corteza Prefrontal/metabolismo , Corteza Prefrontal/patología , Trastornos Relacionados con Sustancias/patología , Sinapsis/metabolismo , Aminoácidos/farmacología , Análisis de Varianza , Animales , Biofisica , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Cocaína/administración & dosificación , Condicionamiento Operante/efectos de los fármacos , Modelos Animales de Enfermedad , Inhibidores de Captación de Dopamina/administración & dosificación , Estimulación Eléctrica , Agonistas de Aminoácidos Excitadores/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Técnicas In Vitro , Depresión Sináptica a Largo Plazo/efectos de los fármacos , Masculino , Técnicas de Placa-Clamp , Escalas de Valoración Psiquiátrica , Ratas , Ratas Sprague-Dawley , Receptores AMPA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Autoadministración , Trastornos Relacionados con Sustancias/metabolismo , Trastornos Relacionados con Sustancias/psicología , Sinapsis/efectos de los fármacos
2.
Rev Mal Respir ; 25(7): 857-60, 2008 Sep.
Artículo en Francés | MEDLINE | ID: mdl-18946412

RESUMEN

INTRODUCTION: Omalizumab, a monoclonal antibody to IgE, is a possible treatment for severe, uncontrolled allergic asthma. CASE REPORT: A severe asthmatic patient with renal insufficiency and on dialysis was awaiting transplantation. The asthma was uncontrolled with poor respiratory function. He received anti IgE treatment with omazilumab with immediate clinical improvement and his renal transplant was performed satisfactorily. CONCLUSION: Anti-IgE treatment can improve severe, uncontrolled allergic asthmatic patients allowing, in this case, transplantation without further respiratory problems.


Asunto(s)
Antiasmáticos/uso terapéutico , Anticuerpos Antiidiotipos , Anticuerpos Monoclonales/uso terapéutico , Asma/tratamiento farmacológico , Trasplante de Riñón , Antiasmáticos/administración & dosificación , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales Humanizados , Asma/complicaciones , Humanos , Masculino , Omalizumab , Diálisis Renal , Insuficiencia Renal/complicaciones , Insuficiencia Renal/cirugía , Insuficiencia Renal/terapia , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
3.
Eur Ann Allergy Clin Immunol ; 39(6): 189-92, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17713170

RESUMEN

Body piercing and tattooing are increasingly common. As well as the risk of infection and scarring, allergic reactions are also reported. This is the first multi-centre study to assess the frequency of consultations for allergy. Of the 138 allergologists who answered our two questionnaires, 7.9% reported allergic reactions associated with body piercing and 18.9% identified allergies associated with temporary henna-based tattoos. Contact eczema, rhinitis and urticaria were related to nickel allergy. Contact eczema, generalized eczema, pruritus and edema were caused by tattoos. In 20 out of 28 cases, sensitization to para-phenylenediamine (PPD) was observed. The authors review the literature, underscoring the risk of serious allergy to PPD, the need for long-term monitoring of the risk of skin lymphocytoma, the difficulties met during treatment and the necessity of regulating tattooing and body piercing practices.


Asunto(s)
Perforación del Cuerpo/efectos adversos , Hipersensibilidad/epidemiología , Hipersensibilidad/etiología , Tatuaje/efectos adversos , Humanos , Estudios Retrospectivos
4.
Rev Med Chil ; 121(7): 785-8, 1993 Jul.
Artículo en Español | MEDLINE | ID: mdl-8296083

RESUMEN

The susceptibility of 45 strains of Neisseria gonorrhoea was studied measuring minimal inhibitory concentrations of five antimicrobials. Results show that 66.7% of strains are resistant to tetracycline and 11.2% to penicillin. All strains were susceptible to ciprofloxacin, ceftriaxone and cefotaxime. This results should prompt to perform surveillance in different areas of Santiago and to establish new therapeutic norms for the treatment of gonococcal infections.


Asunto(s)
Antibacterianos/farmacología , Neisseria gonorrhoeae/efectos de los fármacos , Chile , Farmacorresistencia Microbiana , Humanos , Pruebas de Sensibilidad Microbiana , Neisseria gonorrhoeae/aislamiento & purificación
5.
Rev Med Chil ; 127(8): 919-25, 1999 Aug.
Artículo en Español | MEDLINE | ID: mdl-10752252

RESUMEN

BACKGROUND: During the last decade, there has been a progressive increase in the resistance of gram (+) cocci to betalactamics and other antimicrobials. Therefore, vancomycin and teicoplanin have incorporated as alternative antimicrobial drugs. AIM: To assess the susceptibility of gram (+) cocci to different antimicrobials including vancomycin and teicoplanin. MATERIAL AND METHODS: We studied 447 strains of gram (+) cocci coming from ambulatory and hospitalized patients. These included 308 Enterococcus sp strains, 99 Staphylococcus aureus strains and 40 coagulase negative Staphylococci strains. Enterococci susceptibility was measured using minimal inhibitory concentrations in agar and that of Staphylococci, through diffusion. Susceptibility to vancomycin and teicoplanin was measured using minimal inhibitory concentrations in all strains. RESULTS: Enterococcus faecalis was 100% susceptible to ampicillin, penicillin, vancomycin and teicoplanin, 23% susceptible to tetracyclin and 47% to chloramphenicol. Susceptibility of E faecium was 61% to penicillin, 49% to chloramphenicol, 41% to tetracyclin, 100% to vancomycin and teicoplanin. Of 19 Enterococcus spp strains, 90% were susceptible to ampicillin, 80% to penicillin, 55% to chloramphenicol and 45% to tetracyclin. Only one E casseiflavus strain had a low level resistance to vancomycin and was susceptible to teicoplanin. No Staphylococcus aureus strain was resistant to vancomycin or teicoplanin. CONCLUSIONS: A permanent surveillance of gram (+) cocci antimicrobial susceptibility is required to update therapeutic schemes.


Asunto(s)
Cocos Grampositivos/efectos de los fármacos , Farmacorresistencia Microbiana , Enterococcus/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Staphylococcus/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA